naratriptan 2.5 MG Oral Tablet
1 INDICATIONS AND USAGE Naratriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use: • Use only if a clear diagnosis of migraine has been established. If a patient has no response to the first migraine attack treated with naratriptan tablets, reconsider the diagnosis of migraine before naratriptan tablets are administered to treat any subsequent attacks. • Naratriptan tablets are not indicated for the prevention of migraine attacks. • Safety and effectiveness of naratriptan tablets have not been established for cluster headache. Naratriptan tablets are a serotonin (5-HT 1B/1D ) receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults. ( 1 ) Limitations of Use • Use only if a clear diagnosis of migraine has been established. ( 1 ) • Not indicated for the prophylactic therapy of migraine attacks. ( 1 ) • Not indicated for the treatment of cluster headache. ( 1 )
Mylan Pharmaceuticals Inc.
ROUND GREEN M NN2
Related Pills
naratriptan 1 MG Oral Tablet
Mylan Pharmaceuticals Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Naratriptan Tablets, USP are available containing naratriptan hydrochloride, USP equivalent to 1 mg or 2.5 mg of naratriptan (base). The 1 mg tablets are green, film-coated, round, unscored tablets debossed with M on one side of the tablet and NN1 on the other side. They are available as follows: NDC 0378-4450-59 bottles of 9 tablets The 2.5 mg tablets are green, film-coated, round, unscored tablets debossed with M on one side of the tablet and NN2 on the other side. They are available as follows: NDC 0378-4451-59 bottles of 9 tablets Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.
More pills like ROUND M NN2